Open Access

Towards a new standard of care in coronary and peripheral artery disease: from trial results to guidelines and beyond

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Treatment
Session type: Industry Q&A session
Sponsored by Bayer AG
Date: 31 August 2020
Time: 18:30 - 19:30

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Welcome and introduction.

Speaker: Professor R. Welsh (Edmonton, CA)
Thumbnail

Protecting the patient that needs more: moving from ‘stable coronary artery disease’ to ‘chronic coronary syndromes’.

Speaker: Professor J. Steffel (Zurich, CH)
Thumbnail

How can we protect patients long-term after a percutaneous coronary intervention (PCI)?

Speaker: Professor R. Welsh (Edmonton, CA)
Thumbnail

Protecting the patient undergoing lower extremity revascularization for symptomatic PAD.

Speaker: Professor M. Bonaca (Aurora, US)
Thumbnail

Optimizing protection for patients with symptomatic chronic peripheral artery disease.

Speaker: Professor M. Brodmann (Graz, AT)
Thumbnail

Live Questions and Answers and closing.

Thumbnail

5 speakers from this session

Professor Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)
15 presentations
0 follower

Professor Jan Steffel

Hirslanden Heart Center, Zurich (Switzerland)
52 presentations
6 followers

Professor Robert Welsh

Mazankowski Alberta Heart Institute, Edmonton (Canada)
15 presentations
0 follower

Professor Marc Bonaca

University of Colorado, Aurora (United States of America)
24 presentations
0 follower

Professor Marianne Brodmann

Medical University of Graz, Graz (Austria)
6 presentations
0 follower

This platform is supported by

logo Novo Nordisk